You are here

Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study

Last updated on March 15, 2019

FOR MORE INFORMATION
Study Location
Osteoporosis Medical Center
Beverly Hills, California, 90211 United States
Contact
1-800-718-1021
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Fibromyalgia, Painful Diabetic Peripheral Neuropathy
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18 + years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- A physician-confirmed diagnosis of either pDPN or FM, but not both.

- Initiation of a medication for pDPN or FM is clinically indicated, either as
monotherapy or in combination with other treatments, as determined by the treating
physician, and agreed to by the patient.

- No prior pregabalin use or pregabalin PA requests.

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Age

- Females or are partners of males currently pregnant/lactating or intending to become
pregnant in the next 6 months

- Physician-confirmed diagnosis of both pDPN and FM.

NCT01280747
Pfizer
Terminated
Examination of Pregabalin Access for Treatment of Indicated Pain Disorders: the ExPAND Study

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now